Document Page: First | Prev | Next | All | Image | This Release | Search
File: 102596_sep96_decls3_0001.txt
Subject: MEDICAL PRODUCTS FOR USE DURING DESERT SHIELD
Unit: OTSG
Parent Organization: HSC
Box ID: BX003202
Folder Title: DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GROUP
Document Number: 9
Folder SEQ #: 31
@ro ( I
MEDICAL PRODUCTS FOR USE DURING DESERT SHIELD
Criteria for Consideration:
Address infectious disease threats of Desert Shield
High confidence in safety and potential benefit
Advantage over existing measures
Unlicensed products
Products Already Acquired:
Centoxin
Treatment of Gram-negative Bacterial Sepsis
Distribution
MEDSOM 80 patients
7th MEDCOM 119 patients
WRAMC 1 patient
Ribavirin (Virasole) - Intravenous (10ml vials)
Treatment of Viral Hemorrhagic Fever (CCHF, RVF,
HFRS)
Distribution
MEDSOM 80 patients
7th MEDCOM 5 patients
USAMRIID 15 patients
Ribaviran - Oral (200mg cap 100/btl)
Prophylaxis of medical exposures to Hemorrhagic
Fever
Distribution
MEDSOM 400 people
7th MEDCOM 25 people
USAMRIID 75 people
Additional products that have been considered:
Centoxin (Additional doses)
Hepatitis A Vaccine
Oral Cholera Vaccine
Oral Typhoid Vaccine
Enterotoxigenic E coli (ETEC) Vaccine
West Nile Virus Vaccine
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 5 f:/Week-36/BX003202/DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GROUP/medical products for use during desert shield:1018961354284
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GROUP
Folder Seq # = 31
Subject = MEDICAL PRODUCTS FOR USE DURING DESERT SHIELD
Document Seq # = 9
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 18-OCT-1996